Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study

Detalles Bibliográficos
Autores principales: Caocci, Giovanni, Mulas, Olga, Capodanno, Isabella, Abruzzese, Elisabetta, Iurlo, Alessandra, Luciano, Luigiana, Albano, Francesco, Annunziata, Mario, Tiribelli, Mario, Bonifacio, Massimiliano, Galimberti, Sara, Castagnetti, Fausto, Sgherza, Nicola, Stagno, Fabio, Gozzini, Antonella, Orlandi, Ester Maria, Luzi, Debora, Binotto, Gianni, Pregno, Patrizia, Fozza, Claudio, Efficace, Fabio, Simula, Maria Pina, Trawinska, Malgorzata Monika, Cattaneo, Daniele, De Gregorio, Fiorenza, Attolico, Immacolata, Stella, Rossella, Scaffidi, Luigi, Baratè, Claudia, Gugliotta, Gabriele, Scalzulli, Emilia, Elena, Chiara, Pirillo, Francesca, Foà, Robin, Breccia, Massimo, Nasa, Giorgio La
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280258/
https://www.ncbi.nlm.nih.gov/pubmed/32514110
http://dx.doi.org/10.1038/s41408-020-0333-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280258/
https://www.ncbi.nlm.nih.gov/pubmed/32514110
http://dx.doi.org/10.1038/s41408-020-0333-2

Ejemplares similares